The article highlights the alarming situation in Norway regarding the RSV virus, which accounts for over 1,000 hospital admissions of infants each year. Despite the ongoing RSV season, many more children are suffering from coughs and fevers but remain untreated at home. The author voices concerns over the Norwegian government's lack of action compared to other European nations, where infants receive effective protection against RSV, such as antibodies or vaccines for mothers. Countries like Sweden and Denmark have implemented preventive measures recently, significantly reducing hospitalizations due to RSV infections.

The author points out that the positive impact of preventive healthcare measures has long been recognized by Norwegian health policymakers, yet little decisive action has been taken to expedite evaluations or to adopt these protective strategies. The failure to move swiftly on these recommendations has led to a notable discrepancy in care standards between Norway and its neighbors, putting the health of Norwegian infants at risk.

In light of the current situation, the article calls for immediate action from the Norwegian government to prioritize the health of its youngest citizens. It highlights the growing concern that without intervention, many infants may continue to suffer from RSV without the necessary medical support, emphasizing a need for change in health policy to better protect against respiratory infections in the future.